Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design. - Groarke JD; Crawford J; Collins SM; Lubaczewski SL; Breen DM; Harrington MA; Jacobs I; Qiu R; Revkin J; Rossulek MI; Saxena AR (Journal of cachexia, sarcopenia and muscle, 2024)